Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Advances in Pancreatic Neoplasms"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 19738
A printed edition of this Special Issue is available here.
Special Issue Editor
Interests: chronic pancreatitis; cystic tumors; endocrine tumors; pancreatectomy; pancreatic neoplasms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Pancreatic cancer is the fourth leading of cancer death in Western countries, and is going to become the second cause of gastrointestinal cancer death in the next years. Surgery and adjuvant therapy remains the standard treatment, but the recurrence rate is still high. Multimodality treatment, that is, neoadjuvant therapy and combination of chemotherapy, radiotherapy, immunotherapy, and surgery, appears essential in order to obtain better results, but definitive conclusions are lacking. There is a need for a better understanding of genetic alterations, clarifying the role of new biomarkers for precursor and invasive tumors, the identification of prognostic factors (i.e., nutritional, immunological, and surgical complications), and the management of recurrent cancer for patient’s tailored therapy. Furthermore, neuroendocrine tumors are increasingly recognized in clinical practice, and they include a variety of neoplasms with a different biological behaviour and treatment. In particular, the management of small non-functioning tumors is still controversial, while the treatment of advanced disease requires novel research strategies. The aim of this Special Issue is to focus on the results and problems of multimodality therapy for resectable and locally advanced pancreatic tumors, the search of prognostic factors for early and late outcomes after therapy, and the evaluation of novel strategies for individualized treatment. We are inviting relevant original research, systematic reviews, meta-analyses, and short communications covering the above-mentioned topics.
Prof. Cosimo Sperti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Pancreatic cancer
- Pancreatic neuroendocrine tumor
- Multimodality therapy
- Neoadjuvant therapy
- Nutrition and cancer
- Inflammation and cancer
- Surgical complications and survival
- Recurrent cancer